Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet

Show other versions (1)

Introduction: There is scarce clinical experience with etelcalcetide in patients with secondary hyperparathyroidism uncontrolled with cinacalcet. The effect of etelcalcetide on serum sclerostin levels remains to be clarified. Materials and methods: Prospective cohort study in prevalent hemodialysis...

Full description

Bibliographic Details
Main Authors: Luciano Artur Lopes Pereira, Catarina Meng, Manuel Augusto Gonçalves Amoedo, Maria Teresa de Sousa Costa Pinto Ferreira Mendes, Marco Alexandre Mateus Prazeres Marques, João Miguel Machado Dória Frazão, André Luiz Loureiro Weigert
Format: Article
Language:Spanish
Published: Elsevier 2023-03-01
Series:Nefrología
Subjects:
Hemodiálisis
Hiperparatiroidismo secundario
Etelcalcetida
Esclerostina
Online Access:http://www.sciencedirect.com/science/article/pii/S0211699521002319

Internet

http://www.sciencedirect.com/science/article/pii/S0211699521002319

Similar Items